Related Experiment Video

Updated: May 28, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

Human Metapneumovirus-Is It a Cause for Concern?

Shobha Manish Itolikar1, Milind Nadkar2

  • 1Consultant Physician, Department of Medicine, Fortis Hospital, Mulund, Maharashtra, India, Corresponding Author.

The Journal of the Association of Physicians of India
|February 10, 2025
PubMed

Insights

Emerging infectious diseases remain a significant global threat, despite advancements in civilization. These diseases, caused by pathogens like bacteria and viruses, continue to impact human health and progress.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Historical perspective on infectious diseases, citing Hans Zinsser's 1934 observations.
  • Relevance of microbial threats in the modern era, despite societal development.
  • Emerging infectious diseases as a persistent challenge to global progress.

Purpose of the Study:

  • To underscore the enduring threat of infectious diseases.
  • To highlight the continued relevance of microbial pathogens in contemporary society.
  • To emphasize the impact of emerging infectious diseases on human development.

Main Methods:

  • Review of historical microbiological texts.
  • Analysis of contemporary public health challenges.
  • Comparative assessment of societal development versus infectious disease emergence.

Main Results:

  • Infectious diseases, caused by bacteria, protozoa, viruses, and vectors like ticks and mosquitoes, persist as threats.
  • Despite significant advancements, these microbial agents continue to pose risks to human health.
  • Emerging infectious diseases represent a continuous challenge to global progress.

Conclusions:

  • The threat of infectious diseases is timeless and pervasive.
  • Microbial pathogens remain a fundamental challenge to human civilization.
  • Ongoing vigilance and research are crucial to combat emerging infectious diseases.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.6K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.3K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
168